Figure 1 from Prognostic Impact of Immune-Related Adverse Events on Combination Immune Checkpoint/Tyrosine Kinase Inhibition for Metastatic Renal Cancer

<p>Kaplan–Meier curves by treatment. The red line represents the ICI–ICI group, and the blue line represents the ICI–TKI group.</p>

محفوظ في:

التفاصيل البيبلوغرافية
المؤلف الرئيسي:	Bunpei Isoda (22273897) (author)
مؤلفون آخرون:	Masanobu Shiga (22273900) (author), Shuya Kandori (20806494) (author), Shota Takahashi (22273903) (author), Akifumi Omiya (22273906) (author), Tomoki Ishida (22273909) (author), Kotoe Matsuda (22273912) (author), Hiromichi Sakurai (22273915) (author), Bryan J. Mathis (20803922) (author), Ken Tanaka (22273918) (author), Manabu Komine (22273921) (author), Masahiro Iinuma (22273924) (author), Akira Joraku (22273927) (author), Hiromitsu Negoro (17411086) (author), Masakazu Tsutsumi (22273930) (author), Takamitsu Inoue (22273933) (author), Jun Miyazaki (22273936) (author), Hiroyuki Nishiyama (18287202) (author)
منشور في:	2025
الموضوعات:	Cancer Tumor Biology Molecular and Cellular Biology Immuno-oncology Clinical Research and Trials Antibody Immunotherapy Cell Signaling Clinical-stage Research Genitourinary Cancers Renal cancer Immunotherapy Toxicities/irAEs Immune Cells And The Microenvironment Protein Tyrosine Kinases Tumor Microenvironment
الوسوم:	إضافة وسم لا توجد وسوم, كن أول من يضع وسما على هذه التسجيلة!

مواد مشابهة